The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
123259805 12325980 5 F 201603 20160816 20160503 20160822 EXP US-PFIZER INC-2016225666 PFIZER 82.00 YR M Y 75.00000 KG 20160822 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
123259805 12325980 1 PS SUTENT SUNITINIB MALATE 1 Oral 12 MG, 1X/DAY Y X731C 21938 12 MG CAPSULE, HARD QD
123259805 12325980 2 SS SUTENT SUNITINIB MALATE 1 Oral 50 MG, UNK Y 21938 50 MG CAPSULE, HARD
123259805 12325980 3 SS SUTENT SUNITINIB MALATE 1 Oral 37.5 MG, ONCE A DAY FOR 28 DAYS THEN OFF FOR 2 WEEKS Y 21938 37.5 MG CAPSULE, HARD
123259805 12325980 4 C PLAVIX CLOPIDOGREL BISULFATE 1 UNK 0
123259805 12325980 5 C ALLOPURINOL. ALLOPURINOL 1 Oral 300 MG, DAILY 0 300 MG TABLET
123259805 12325980 6 C AMLODIPINE BESYLATE. AMLODIPINE BESYLATE 1 Oral 10 MG, DAILY 0 10 MG TABLET
123259805 12325980 7 C CLOPIDOGREL BISULFATE. CLOPIDOGREL BISULFATE 1 Oral 75 MG, DAILY 0 75 MG TABLET
123259805 12325980 8 C FINASTERIDE. FINASTERIDE 1 Oral 5 MG, DAILY (AT BEDTIME) 0 5 MG TABLET
123259805 12325980 9 C HYDRALAZINE HCL HYDRALAZINE HYDROCHLORIDE 1 Oral 25 MG, 3X/DAY 0 25 MG TABLET TID
123259805 12325980 10 C LEVOTHYROXINE SODIUM. LEVOTHYROXINE SODIUM 1 Oral 75 UG, DAILY (EVERY MORNING) 0 75 UG TABLET
123259805 12325980 11 C LOSARTAN POTASSIUM. LOSARTAN POTASSIUM 1 Oral 50 MG, DAILY 0 50 MG TABLET
123259805 12325980 12 C METOPROLOL TARTRATE. METOPROLOL TARTRATE 1 Oral 25 MG, 2X/DAY 0 25 MG TABLET BID
123259805 12325980 13 C ONDANSETRON ONDANSETRON 1 Oral 4 MG, AS NEEDED (EVERY 6 HRS) 0 4 MG DISPERSIBLE TABLET
123259805 12325980 14 C ONDANSETRON ONDANSETRON 1 0 DISPERSIBLE TABLET
123259805 12325980 15 C ESCITALOPRAM ESCITALOPRAM OXALATE 1 5 MG, 1X/DAY (AT BEDTIME) 0 5 MG QD
123259805 12325980 16 C CITALOPRAM CITALOPRAM HYDROBROMIDE 1 UNK 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
123259805 12325980 1 Renal cell carcinoma
123259805 12325980 4 Stent placement
123259805 12325980 13 Nausea
123259805 12325980 14 Vomiting

Outcome of event

Event ID CASEID OUTC COD
123259805 12325980 OT
123259805 12325980 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
123259805 12325980 Carcinoid tumour
123259805 12325980 Diarrhoea
123259805 12325980 Disease progression
123259805 12325980 Hypertension
123259805 12325980 Malaise
123259805 12325980 Nausea
123259805 12325980 Renal cell carcinoma
123259805 12325980 Second primary malignancy
123259805 12325980 Vomiting

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
123259805 12325980 1 2014 0
123259805 12325980 2 20160414 0
123259805 12325980 3 201605 0
123259805 12325980 5 20160509 0
123259805 12325980 6 20160509 0
123259805 12325980 7 20160509 0
123259805 12325980 8 20160509 0
123259805 12325980 9 20160509 0
123259805 12325980 10 20160509 0
123259805 12325980 11 20160509 0
123259805 12325980 12 20160509 0
123259805 12325980 13 20160509 0